mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |